JaxBio develops a simple, fast, and highly sensitive blood test for the early diagnosis of cancer. Their technology utilizes artificial intelligence to probe thousands of cancer-specific biomarkers, enabling the identification of different cancer types and subtypes at various stages. This aims to improve cancer detection, monitoring, and treatment response prediction.